Abstract
Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have